Don't expect GDP growth to turn positive in FY21: Nirmal Bang

The GDP growth in the April-June quarter is likely to decline by around 16.8 percent year-on-year, according to a research report by Nirmal Bang .

Moneycontrol News

August 28, 2020 / 17:29 IST

The Central Statistical Organisation will release the gross domestic product (GDP) data for the June quarter of FY21 on August 31, which will reflect the economic impact of the lockdown that started on March 25 and is being eased in a phased manner. The GDP in Q1FY21 is likely to decline by around 16.8 percent, YoY, according to the Nirmal Bang research report.

Highlights of the report:

Agriculture and Allied sector and public administration, defence and other services are expected to remain in the positive territory, with all other sectors witnessing a sharp contraction.

Trade, hotels, transport, and communication sectors are expected to be the worst hit with a 40 percent year-on-year (YoY) decline, pulling down the services sector (including construction) by 19.8 percent, YoY.

Led by a decline in the manufacturing sector, the industry is likely to contract by 18.5 percent YoY. Despite Q1FY21 GDP being broadly in line with our initial estimate, we are sharply revising down FY21 GDP to negative 7.8 percent from negative 3.3% on account of downward revisions from Q2 to Q4FY21.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show